The emerging roles of Jab1/CSN5 in cancer

被引:0
|
作者
Lin Wang
Jun-Nian Zheng
Dong-Sheng Pei
机构
[1] Xuzhou Medical University,Department of Pathology
[2] Xuzhou Medical University,Jiangsu Key Laboratory of Biological Cancer Therapy
[3] Xuzhou Medical University,Jiangsu Center for the Collaboration and Innovation of Cancer Biotherapy
[4] Affiliated Hospital of Xuzhou Medical University,Center of Clinical Oncology
来源
Medical Oncology | 2016年 / 33卷
关键词
Jab1/CSN5; Ubiquitination; Cancer; Proliferation; Cell cycle; DDR;
D O I
暂无
中图分类号
学科分类号
摘要
C-Jun activation domain-binding protein-1 (Jab1) not only is full but also a subunit (CSN5) of the constitutive photomorphogenesis 9 signalosome (CSN), which is an evolutionarily conserved and multifunctional protein that involves in controlling cellular proliferation and apoptosis, affecting a series of pathways, as well as regulating genomic instability and DNA damage and repair. The CSN is a highly conservative protein from yeast to human and interacts with the cullin-RING family of ubiquitin ligases so that it could be execute a process of removing NEDD8, a ubiquitin-like polypeptide (deneddylase activity). The role of Jab1/CSN5’s multi-function has been proved as being oncogenic in nature, what is more, Jab1/CSN5 has been confirmed by much evidence that it participates in the carcinogenesis progression and is tightly associated with poor prognosis. However, the biologic implication of Jab1/CSN5 activity during the cancer’s development is unclear. We performed a systematic literature review and assessment from PubMed and Medline databases in this article. Jab1/CSN5 is participate in a lot of biologic responses, including cell proliferation, apoptosis, cell cycle regulation, DNA metabolism, invasion, DNA damage and repair, and recurrence. It also promotes cell transformation and tumorigenesis. In this review, we mainly expound the progress in the function and research advances of Jab1/CSN5 and in untangling the Jab1/CSN5 signaling pathway. Based on these bases, its potential as a therapeutic target for cancer can play a greater role in future cancer treatment.
引用
收藏
相关论文
共 50 条
  • [1] The emerging roles of Jab1/CSN5 in cancer
    Wang, Lin
    Zheng, Jun-Nian
    Pei, Dong-Sheng
    MEDICAL ONCOLOGY, 2016, 33 (08)
  • [2] Emerging roles of Jab1/CSN5 in DNA damage response, DNA repair, and cancer
    Pan, Yunbao
    Yang, Huiling
    Claret, Francois X.
    CANCER BIOLOGY & THERAPY, 2014, 15 (03) : 256 - 262
  • [3] Targeting Jab1/CSN5 in nasopharyngeal carcinoma
    Pan, Yunbao
    Claret, Francois X.
    CANCER LETTERS, 2012, 326 (02) : 155 - 160
  • [4] MAbs against mammalian Jab1/CSN5 protein
    Kato, Jun-Ya
    HYBRIDOMA, 2006, 25 (06): : 387 - 387
  • [5] JAB1/CSN5: a new player in cell cycle control and cancer
    Terry J Shackleford
    Francois X Claret
    Cell Division, 5
  • [6] JAB1/CSN5: a new player in cell cycle control and cancer
    Shackleford, Terry J.
    Claret, Francois X.
    CELL DIVISION, 2010, 5
  • [7] Role of CSN5/JAB1 in Wnt/β-catenin activation in colorectal cancer cells
    Schuetz, Anke K.
    Hennes, Thomas
    Jumpertz, Sandra
    Fuchs, Simone
    Bernhagen, Juergen
    FEBS LETTERS, 2012, 586 (11): : 1645 - 1651
  • [8] Stat3 contributes to cancer progression by regulating Jab1/Csn5 expression
    Pan, Y.
    Wang, S.
    Su, B.
    Zhou, F.
    Zhang, R.
    Xu, T.
    Zhang, R.
    Leventaki, V.
    Drakos, E.
    Liu, W.
    Claret, F. X.
    ONCOGENE, 2017, 36 (08) : 1069 - 1079
  • [9] Stat3 contributes to cancer progression by regulating Jab1/Csn5 expression
    Y Pan
    S Wang
    B Su
    F Zhou
    R Zhang
    T Xu
    R Zhang
    V Leventaki
    E Drakos
    W Liu
    F X Claret
    Oncogene, 2017, 36 : 1069 - 1079
  • [10] JAB1/CSN5 and the COP9 signalosome - A complex situation
    Chamovitz, DA
    Segal, D
    EMBO REPORTS, 2001, 2 (02) : 96 - 101